Eli Lilly and Company (NYSE: LLY) has agreed to acquire Merida Biosciences, Inc., a biotechnology company developing treatments for autoimmune ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE